BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24576777)

  • 1. Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma.
    Chen H; Miao J; Li H; Wang C; Li J; Zhu Y; Wang J; Wu X; Qiao H
    J Surg Res; 2014 Jun; 189(1):81-8. PubMed ID: 24576777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
    Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
    Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma.
    Liu W; Liu Y; Liu H; Zhang W; Fu Q; Xu J; Gu J
    J Biol Chem; 2015 Nov; 290(47):28489-28501. PubMed ID: 26442588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.
    Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J
    J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyoxylate reductase/hydroxypyruvate reductase: a novel prognostic marker for hepatocellular carcinoma patients after curative resection.
    Pan Y; Ni R; Deng Q; Huang X; Zhang Y; Lu C; Li F; Huang D; He S; Chen B
    Pathobiology; 2013; 80(3):155-62. PubMed ID: 23486161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
    Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
    Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
    Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
    Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor.
    Fujii T; Koshikawa K; Nomoto S; Okochi O; Kaneko T; Inoue S; Yatabe Y; Takeda S; Nakao A
    J Hepatol; 2004 Jul; 41(1):104-11. PubMed ID: 15246215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.
    Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH
    J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
    Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
    Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinoma.
    Zhang Z; Qin C; Wu Y; Su Z; Xian G; Hu B
    Oncol Rep; 2014 Apr; 31(4):1629-36. PubMed ID: 24481516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.